Related references
Note: Only part of the references are listed.Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells
D. Mahalingam et al.
BRITISH JOURNAL OF CANCER (2010)
Smoothened as a new therapeutic target for human osteosarcoma
Masataka Hirotsu et al.
MOLECULAR CANCER (2010)
Regulation of cell signalling by uPAR
Harvey W. Smith et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
EGR1 reactivation by histone deacetylase inhibitors promotes synovial sarcoma cell death through the PTEN tumor suppressor
L. Su et al.
ONCOGENE (2010)
Targeting the cancer kinome through polypharmacology
Zachary A. Knight et al.
NATURE REVIEWS CANCER (2010)
A γ-Secretase Inhibitor Decreases Amyloid-β Production in the Central Nervous System
Randall J. Bateman et al.
ANNALS OF NEUROLOGY (2009)
Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells
M. Hirotsu et al.
BRITISH JOURNAL OF CANCER (2009)
Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation
M. Tanaka et al.
BRITISH JOURNAL OF CANCER (2009)
Osteosarcoma treatment: state of the art
Hang T. Ta et al.
CANCER AND METASTASIS REVIEWS (2009)
Targeting Sarcomas: Novel Biological Agents and Future Perspectives
Devalingam Mahalingam et al.
CURRENT DRUG TARGETS (2009)
PTEN regulation by Akt-EGR1-ARF-PTEN axis
Jianxiu Yu et al.
EMBO JOURNAL (2009)
Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
David B. Henley et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
Lisa Mirabello et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J
Yukihide Iwamoto et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2009)
Transforming Growth Factor β1-mediated Activation of the Smooth Muscle α-Actin Gene in Human Pulmonary Myofibroblasts Is Inhibited by Tumor Necrosis Factor-α via Mitogen-activated Protein Kinase Kinase 1-dependent Induction of the Egr-1 Transcriptional Repressor
Xiaoying Liu et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease
Adam S. Fleisher et al.
ARCHIVES OF NEUROLOGY (2008)
Tumour-targeted nanomedicines: principles and practice
T. Lammers et al.
BRITISH JOURNAL OF CANCER (2008)
Urokinase plasminogen activator receptor choreographs multiple ligand interactions: Implications for tumor progression and therapy
Andrew P. Mazar
CLINICAL CANCER RESEARCH (2008)
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Jordi Rius et al.
NATURE (2008)
Local recurrence and local control of non-metastatic osteosarcoma of the extremities: A 27-year experience in a single institution
Gaetano Bacci et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup
Ian J. Lewis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta
Yao Chang et al.
JOURNAL OF VIROLOGY (2006)
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin
V Baron et al.
CANCER GENE THERAPY (2006)
Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10
J Kim et al.
CANCER RESEARCH (2006)
Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy
G Bacci et al.
EUROPEAN JOURNAL OF CANCER (2005)
Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma
Crispin R. Dass et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells
CE de Bock et al.
FEBS JOURNAL (2005)
Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
PA Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein
SJ Baek et al.
MOLECULAR PHARMACOLOGY (2005)
Egr-1 is activated by 17β-estradiol in MCF-7 cells by mitogen-activated protein kinase-dependent phosphorylation of ELK-1
CC Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma
EG MacEwen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Molecular mechanisms of glioma invasiveness: The role of proteases
JS Rao
NATURE REVIEWS CANCER (2003)
The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells
A Quiñones et al.
LIFE SCIENCES (2003)
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric oncology group study POG-8651
AM Goorin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults
SJ Patel et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
SS Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251
CT Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
